Erratum to: Targ Oncol (2016) 11:557–563
DOI 10.1007/s11523-015-0410-9
The article Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case Report, written by Andrew J. Dooley, Avinash Gupta and Mark R. Middleton, was originally published Online First without open access. After publication in volume 11, issue 4, page 557-563 the author decided to opt for Open Choice and to make the article an open access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2016 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s11523-015-0410-9.
Rights and permissions
About this article
Cite this article
Dooley, A.J., Gupta, A. & Middleton, M.R. Erratum to: Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case Report. Targ Oncol 12, 385 (2017). https://doi.org/10.1007/s11523-017-0483-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11523-017-0483-8